Maravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary

• Maravai LifeSciences Holdings Inc MRVI.OQ reported a quarterly adjusted loss of 8 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported breakeven earnings per share. The mean expectation of twelve analysts for the quarter was for a loss of 7 cents per share. Wall Street expected results to range from -9 cents to -4 cents per share.

• Revenue fell 35.4% to $47.40 million from a year ago; analysts expected $47.37 million.

• Maravai LifeSciences Holdings Inc's reported EPS for the quarter was a loss of 27 cents​.

• The company reported a quarterly loss of $39.59 million.

• Maravai LifeSciences Holdings Inc shares had fallen by 8.7% this quarter and lost 59.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Maravai LifeSciences Holdings Inc is $5.00, about 56% above its last closing price of $2.20

This summary was machine generated from LSEG data August 11 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)